Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Ocumension Acquires all the Equity Interests in Two Ophthalmic Products Mainland China, Further Enhancing its Pipeline Strength 2021-08-25 12:35
Brii Biosciences Announces Positive Data from the Phase 3 ACTIV-2 Trial Evaluating Combination BRII-196 and BRII-198 in Non-Hospitalized COVID-19 Patients 2021-08-25 08:42
Ascletis Announces Completion of the Bridging Study and Initiation of Phase II Trial of FXR Agonist ASC42 in China for Chronic Hepatitis B Indication 2021-08-25 08:30
CBC-led Consortium Acquires Significant Equity Interest in Korea's Largest Medical Aesthetics Company 2021-08-25 07:50
Let's talk Lady Parts for Ovarian Cancer Awareness Month with President & CEO of OCRA, Audra Moran 2021-08-25 07:33
Athos Therapeutics Announces Research Collaboration with Cleveland Clinic to Advance Precision Medicine in Inflammatory Bowel Disease 2021-08-25 01:00
Solbasium Unveils the World's First Red Light Therapy Roller 2021-08-24 23:07
Ping An Good Doctor posts 39% revenue growth in the first half of 2021; Revenue from medical services grows 50.6%; Total number of registered users reaches 400 million 2021-08-24 23:03
GenScript Biotech Reports First Half 2021 Results 2021-08-24 21:38
MFDS Greenlights VUNO Med®-DeepCARS™, AI Medical Device for Cardiac Arrest Prediction 2021-08-24 21:00
SAMⓇ Pain Management and Soft-Tissue Healing Ultrasound Device to be Showcased at National Chiropractic Convention 2021-08-24 20:00
ASX Announcement: AdAlta and Carina Biotech to develop next-generation CAR-T cancer therapeutics 2021-08-24 19:26
Ascentage Pharma Announces 2021 Interim Results Highlighting the Potential of Its Core Drug Candidates and Major Breakthroughs in Strategic Collaborations 2021-08-24 19:06
Kintor Pharma to Report 2021 Interim Financial Results and Host Conference Call on August 30, 2021 2021-08-24 17:04
Alphamab Oncology and CSPC Achieved an Licensing Cooperation on Anti-HER2 Bispecific Antibody KN026 in Mainland China 2021-08-24 15:08
China Medical System Holdings Limited 2021 Interim Results Announcement 2021-08-24 10:52
Antengene Announces Approval of the Phase II Study of Selinexor for the Treatment of Myelofibrosis in China 2021-08-24 08:30
Genscript Biotech Reports 2021 Interim Financial Results 2021-08-24 01:32
Himalaya Therapeutics Announces Registration of its Office in Shanghai 2021-08-23 22:10
Hepagene Therapeutics, Inc. Announces Positive Results from Phase I Trial of HPG1860 2021-08-23 22:00
1 352 353 354 355 356 892